Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammatory Breast Neoplasms × Methods × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 41 Neoplasms 34 Lung Neoplasms 22 Colorectal Neoplasms 22 Prostatic Neoplasms 15 Motor Activity 12 Uterine Cervical Neoplasms 11 Colonic Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Melanoma 8 Anxiety Disorders 8 Urinary Bladder Neoplasms 7 Obesity 7 Lymphoma 7 Hematologic Neoplasms 7 Head and Neck Neoplasms 6 Depression 6 Breast Carcinoma In Situ 6 Vulvar Neoplasms 5 Pain 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Endometrial Neoplasms 5 Stomach Neoplasms 4 Sarcoma 4 Papillomavirus Infections 4 Fatigue 4 Vaginal Neoplasms 3

Interventions

Cyclophosphamide 29 Epirubicin 18 Paclitaxel 16 Trastuzumab 15 Docetaxel 15 Doxorubicin 14 Radiotherapy 12 Carboplatin 11 Filgrastim 9 Taxes 7 Neoadjuvant Therapy 7 Tamoxifen 6 Capecitabine 6 Albumin-Bound Paclitaxel 6 pembrolizumab 5 Thiotepa 5 Peripheral Blood Stem Cell Transplantation 5 Lapatinib 5 Fluorouracil 5 Bevacizumab 5 pertuzumab 4 Granulocyte Colony-Stimulating Factor 4 Chemotherapy, Adjuvant 4 Biopsy 4 130-nm albumin-bound paclitaxel 4 tipifarnib 3 eribulin 3 Surgical Procedures, Operative 3 Specimen Handling 3 Melphalan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07474090 2026-03-16

STEPS-BC

Wake Forest University Health Sciences

Phase NA Not yet recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡